CCL2 has pro-tumor effects and CCL2 affects vascular endothelial cells through the JAK2-STAT5 and P38 mitogen-activated protein kinase pathways, regulating tumor vascularization and tumor metastasis (33). The gene discussed is JAK2; the disease is neoplasm.